Delcath Systems Inc Quick Ratio (DCTH) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Delcath Systems Inc   (NASDAQ: DCTH)

Delcath Systems Inc 's Quick Ratio

DCTH's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Delcath Systems Inc 's Cash & cash equivalent grew by 8.77 % in the Q3 2026 sequentially, while Current Liabilities decreased, this led to improvement in Delcath Systems Inc 's Quick Ratio to 8.01, above Delcath Systems Inc average Quick Ratio.

Within Medical Equipment & Supplies industry 18 other companies have achieved higher Quick Ratio than Delcath Systems Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 267 to 542.

Explain Quick Ratio?
How much Cash & cash equivalents DCTH´s has?
What are DCTH´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/DCTH/financial-strength
https://api.csimarket.com/api/v1/companies/DCTH/fundamentals
https://api.csimarket.com/api/v1/companies/DCTH/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
DCTH Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Current Liabilities Change 64.81 %
Y / Y Cash & cash equivalent Change 17.32 %
Quick Ratio MRQ 8.01
DCTH's Total Ranking # 542
Seq. Current Liabilities Change -1.94 %
Seq. Cash & cash equivalent Change 8.77 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 19
Healthcare Sector # 229
Overall Market # 542


Quick Ratio Statistics
High Average Low
11.38 3.11 0.05
(Mar 31 2025)   (Jun 30 2019)




Financial Statements
Delcath Systems Inc 's Current Liabilities $ 13 Millions Visit DCTH's Balance sheet
Delcath Systems Inc 's Cash & cash equivalent $ 104 Millions Visit DCTH's Balance sheet
Source of DCTH's Sales Visit DCTH's Sales by Geography


Cumulative Delcath Systems Inc 's Quick Ratio

DCTH's Quick Ratio for the trailling 12 Months

DCTH Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 62.24 %
Y / Y Cash & cash equivalent TTM Growth 34.93 %
Quick Ratio TTM 7.97
Total Ranking TTM # 3631
Seq. Current Liabilities TTM Growth 12.01 %
Seq. Cash & cash equivalent TTM Growth 4.22 %


On the trailing twelve months basis Due to decrease in Current Liabilities in the Q3 2026 to $13.02 millions, cumulative Quick Ratio decreased to 7.97 above the DCTH average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 194 other companies have achieved higher Quick Ratio than Delcath Systems Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 1921 to 3631.

Explain Quick Ratio?
How much Cash & cash equivalents DCTH´s has?
What are DCTH´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 195
Healthcare Sector # 866
Within the Market # 3631


trailing twelve months Quick Ratio Statistics
High Average Low
5.3 2.22 0.18
(Mar 31 2014)   (Jun 30 2019)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Bone Biologics Corporation  12.66 $ 6.088  Millions$ 0.481  Millions
Anteris Technologies Global Corp   11.37 $ 216.987  Millions$ 19.085  Millions
Lemaitre Vascular Inc   11.26 $ 389.721  Millions$ 34.620  Millions
Mobia Medical Inc   10.63 $ 160.692  Millions$ 15.115  Millions
Axogen inc   9.55 $ 348.068  Millions$ 36.456  Millions
Delcath Systems Inc   8.01 $ 104.315  Millions$ 13.022  Millions
Orchestra Biomed Holdings Inc   7.16 $ 101.907  Millions$ 14.228  Millions
Envveno Medical Corporation  7.13 $ 18.472  Millions$ 2.589  Millions
Ceribell Inc   6.51 $ 117.467  Millions$ 18.034  Millions
Autonomix Medical Inc   6.13 $ 7.692  Millions$ 1.254  Millions
Iradimed Corporation  6.13 $ 63.288  Millions$ 10.323  Millions
Orasure Technologies Inc  5.90 $ 148.238  Millions$ 25.104  Millions
Perspective Therapeutics Inc   5.09 $ 201.695  Millions$ 39.602  Millions
Clearpoint Neuro Inc   4.68 $ 46.184  Millions$ 9.869  Millions
Cvrx inc   4.67 $ 58.746  Millions$ 12.583  Millions
Dexcom Inc   4.25 $ 964.800  Millions$ 227.000  Millions
Innovative Eyewear Inc   3.86 $ 3.197  Millions$ 0.829  Millions
Sight Sciences Inc   3.84 $ 77.402  Millions$ 20.137  Millions
Alpha Pro Tech Ltd   3.78 $ 25.546  Millions$ 6.750  Millions
Hyperfine Inc   3.60 $ 37.872  Millions$ 10.532  Millions
Profound Medical Corp   3.41 $ 33.343  Millions$ 9.771  Millions
Rxsight Inc   3.40 $ 254.683  Millions$ 74.952  Millions
Omada Health Inc   3.23 $ 243.151  Millions$ 75.379  Millions
Transmedics Group Inc   3.22 $ 492.962  Millions$ 152.857  Millions
Trisalus Life Sciences Inc   3.15 $ 41.057  Millions$ 13.014  Millions
Procept Biorobotics Corporation  3.10 $ 218.369  Millions$ 70.353  Millions
Carlsmed Inc   3.08 $ 56.207  Millions$ 18.237  Millions
Outset Medical Inc   3.07 $ 136.627  Millions$ 44.453  Millions
Sharps Technology Inc   2.82 $ 7.478  Millions$ 2.650  Millions
Edwards Lifesciences Corporation  2.81 $ 4,683.700  Millions$ 1,664.300  Millions

Date modified: 2026-11-10T09:59:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.